• Pomalidomide (CC-4047): A Genotype-Aware Guide

  2026-08-20

  Pomalidomide (CC-4047) can support more informative multiple myeloma and hematological malignancy research when compound response is interpreted alongside model genotype, cytokine biology, and assay context. This guide translates exome-based cell-line findings into practical, evidence-aware experimental decisions.

• Mycobacterium tuberculosis WecA: Purification and Kinetics

  2026-08-20

  The reference study establishes a practical expression, purification, and activity-analysis workflow for Mycobacterium tuberculosis WecA, an 11-transmembrane-domain enzyme involved in mycobacterial cell-wall biosynthesis. By combining regulated heterologous expression with affinity purification, mass-spectrometric identification, UMP-based product detection, and inhibition analysis, the work makes this difficult membrane target more accessible for biochemical drug-discovery studies.

• Cytarabine Workflows for Apoptosis Research

  2026-08-19

  Cytarabine and AraC provide a practical DNA-replication stress tool for leukemia apoptosis studies, resistance profiling, and carefully controlled cell-death experiments. This guide connects those workflows with the RIPK3-focused reference study while clearly separating established evidence from exploratory virology applications.

• Grazoprevir hydrate in HCV Cell Assays

  2026-08-19

  A scenario-driven guide to using Grazoprevir hydrate, SKU C8713, in HCV replication and cell-viability workflows. It explains assay controls, dose-response design, interpretation of genotype-specific EC50 values, and practical criteria for selecting a reliable research reagent.

• Salmonella Haem, Phagocytosis, and Virulence

  2026-08-18

  A recent Nature Microbiology study identifies the Salmonella methyltransferase SirM as a regulator of haem biosynthesis and macrophage evasion. By modifying HemL, SirM increases bacterial haem production, suppresses TLR4-dependent Cdc42 activation, reduces phagocytosis, and enhances virulence in mice.

• Gemcitabine Workflows for DNA Damage Research

  2026-08-18

  Build reproducible Gemcitabine experiments around replication arrest, checkpoint signaling, and apoptosis rather than relying on a single viability endpoint. This guide connects dose timing, orthogonal assays, osteosarcoma models, and an emerging IL-6/GP130 hypothesis to help researchers distinguish mechanism from nonspecific toxicity.

• Ibrexafungerp (MK 3118): Mechanism and Evidence

  2026-08-17

  Ibrexafungerp, also called MK 3118 or SCY-078, is an oral triterpenoid antifungal that inhibits 1,3-β-D-glucan synthase. Clinical approval supports vulvovaginal candidiasis and recurrent vulvovaginal candidiasis reduction, while resistance-focused laboratory evidence supports further investigation in Candida infections.

• Methicillin Sodium Salt for MSSA Research

  2026-08-17

  Methicillin sodium salt provides a defined, penicillinase-resistant benchmark for MSSA susceptibility, cell-wall inhibition, and MRSA resistance studies. This guide connects practical dilution workflows with phenotype-to-target strategies inspired by high-throughput antibacterial discovery research.

• Antiarrhythmic Drugs and Cardiac KCa2 Channels

  2026-08-16

  This 2017 study systematically tested antiarrhythmic drugs against human small-conductance calcium-activated potassium channels using automated whole-cell patch clamp. It found that only dofetilide and propafenone inhibited hKCa2.2 and hKCa2.3, with potencies substantially weaker than their free therapeutic plasma concentrations, arguing against a major clinical contribution from KCa2 blockade.

• Urine Nanosensor for Early Atherosclerosis Detection

  2026-08-15

  Wu and colleagues developed an enzyme-responsive carbon quantum dot nanosensor that converts atherosclerosis-associated proteolytic activity into a urinary fluorescence signal. In mice, the assay distinguished early atherosclerotic disease from healthy controls and showed no notable toxicity, supporting further study of minimally invasive activity-based biomarkers.

• WDR36, Glycolysis, and Human Trophectoderm Fate

  2026-08-14

  A recent Advanced Science study uses mouse embryos and human pluripotent stem cell-derived blastoids to show that WDR36 supports trophectoderm differentiation through glycolytic metabolism. The work links WDR36 to LDHA-associated glucose metabolism and provides a mechanistic framework for interpreting early developmental arrest.

• pH-Sensitive Nanoparticles Reverse BCSC Drug Resistance

  2026-08-14

  The reference study developed SchB/AP nanoparticles that combine an ATRA-grafted pH-sensitive polymer with schisandrin B to address multidrug resistance in breast cancer stem cells. Its in vitro findings connect pH-responsive release, lysosomal escape, P-glycoprotein suppression, and altered energy supply, while also highlighting the need for further in vivo validation.

• ERK5 and Vitamin D–Driven AML Differentiation

  2026-08-13

  Wang et al. show that ERK5 contributes substantially to 1α,25-(OH)2 vitamin D3-induced differentiation of HL60 and U937 myeloid leukemia cells, but its role differs from that of the canonical ERK1/2 pathway. Pharmacological ERK5 inhibition enhanced CD11b expression while suppressing CD14 and imposing G1- or G2-associated cell-cycle arrest, highlighting pathway-selective control of leukemia-cell maturation.

• EIF4A3–circEIF2S2 Axis in Colorectal Cancer

  2026-08-13

  The reference study identifies an EIF4A3–circEIF2S2–miR-646–UHMK1 regulatory axis that connects circular RNA biogenesis with colorectal cancer growth, metastasis, and immune suppression. Its combined molecular, cellular, co-culture, and xenograft evidence positions circEIF2S2 as a mechanistically testable target while also illustrating how proliferation measurements can complement metastasis and immune-function assays.

• Neuromedin S (rat): GPCR Assay Guide

  2026-08-12

  Neuromedin S (rat) provides a defined endogenous peptide input for controlled neuromedin U receptor signaling and GPCR/G protein assay development. It is intended for laboratory research with validated rat-relevant assay systems, not for diagnostic, therapeutic, or medical use.

16701 records 1/1114 page Next 12345 下5页 Last page